Millennial Potash Corp (TSX-V:MLP, OTCQB:MLPNF) said that two new infrastructure projects being developed in Gabon are expected to improve the operational prospects of its Banio potash project.
The company highlighted the completion of Phase 1 of the Mangali Port near Mayumba, a public-private partnership between the Gabonese government and the African Conservation Development Group.
Draftkings Inc (NASDAQ:DKNG) is set to report its first quarter earnings on May 8, with investor focus expected to shift beyond the known March Madness headwinds toward the company’s 2025 outlook and its ability to reaccelerate handle growth to reach its revenue guidance.
Bank of America analysts have adjusted their expectations downward for the quarter, with EBITDA estimates now at $120 million, revised from $149 million due to a weaker March hold.
CoreWeave (NASDAQ:CRWV), a leading AI datacenter platform, has earned a ‘Buy’ rating and $42 price objective from Bank of America analysts in their initial coverage of the company.
Analysts believe CoreWeave is well-positioned to take share in the rapidly expanding AI Infrastructure-as-a-Service (IaaS) market, which is projected to reach $79 billion by 2028, growing at a 62% three-year compound annual growth rate (CAGR).
Shares of General Electric Co (NYSE:GE) climbed 4% on Tuesday morning after GE Aerospace posted better-than-expected first-quarter earnings, driven by strong demand for commercial engine maintenance and gains in its defense business, and reaffirmed its full-year forecast.
The aerospace supplier reported adjusted earnings per share of $1.49 for the quarter ended March 31, topping analysts' average estimate of $1.27, according to LSEG data.
RTX Corp (NYSE:RTX, ETR:5UR) shares plunged after the defense and aerospace company warned that recently announced tariffs may negatively impact its full-year performance.
The company expects adjusted sales in the range of $83 billion to $84 billion and adjusted earnings per share (EPS) between $6 to $6.15 for 2025, but noted that this does not include the potential impact of tariffs.
Lockheed Martin Corp (NYSE:LMT) delivered stronger-than-expected first-quarter results, posting solid gains in profit and revenue that topped Wall Street forecasts, and reaffirmed its full-year outlook despite a mixed performance across business segments.
Earnings per share of $7.28 were up from $6.39 in the year-ago quarter and beat estimates of $6.31.
Verizon Communications Inc (NYSE:VZ, ETR:BAC) shares moved lower after the telecommunications firm posted a larger-than-expected drop in wireless subscribers.
For Q1, Verizon saw a net loss of 289,000 retail postpaid phone subscribers, worse than a decline of 218,000 expected.
3M Co (NYSE:MMM) reported better-than-expected earnings for the first quarter of 2025 on Tuesday, driven by organic growth and margin expansion, but warned that new tariffs could shave as much as $0.40 off its full-year profit.
The industrial conglomerate, known for products ranging from adhesives to safety equipment, said adjusted earnings per share rose 10% year-over-year to $1.88, while total revenue came in at $6 billion, down 1% from the same period last year.
Shares in Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) rose as much as 6% on Tuesday morning after the company announced a licensing agreement that will see its iron deficiency treatment ACCRUFeR brought to the Japanese market.
The deal, signed with Tokyo-based VITAL-NET, gives the Japanese group exclusive rights to develop and commercialise the drug in Japan.
Shares in Celebrus Technologies PLC (AIM:D4T4, OTC:DFORF) plummeted 19% after the data solutions provider provided a trading update with a fairly important mistake, which required a swift correction.
The AIM-listed firm clarified that revenue would be lower than expected for FY2025 rather than FY2026, as it had originally said.
Shares in Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013) rose 10% in early trading on Tuesday after the biopharma company announced it had completed patient enrolment for a key phase II trial of its cancer drug savolitinib in China.
The study is testing the treatment in people with gastric or gastroesophageal junction cancer whose tumours show MET gene amplification – a relatively rare but aggressive subtype.
Shares in precious metals miners Fresnillo PLC (LSE:FRES) and Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) led the FTSE 100 in early trading on Tuesday, buoyed by a surge in gold prices to an all-time high.
Spot gold began to challenge the $3,500 an ounce level during the morning session, driven by investor demand for safe-haven assets amid political tensions in the US.